ReviewFrontiers in immunology2018

Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.

Ciprian Tomuleasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.